MyFinsight
Home
Blog
About
Accounts receivable
$6,311K
(-12.72%↓ Y/Y)
Cash and cash
equivalents
$2,688K
(435.46%↑ Y/Y)
Other current assets
$1,969K
(11.18%↑ Y/Y)
Deferred tax asset
$20,915K
Total current assets
$10,968K
(15.40%↑ Y/Y)
Property and equipment,
net
$1,621K
(18.67%↑ Y/Y)
Operating lease right of
use assets
$1,001K
(-29.51%↓ Y/Y)
Other long-term
assets
$44K
(-2.22%↓ Y/Y)
Total assets
$34,549K
(180.09%↑ Y/Y)
Total liabilities and
stockholders equity
$34,549K
(180.09%↑ Y/Y)
Total stockholders
equity
$23,244K
(2016.24%↑ Y/Y)
Total liabilities
$11,305K
(-16.56%↓ Y/Y)
Accumulated deficit
-$209,926K
(10.43%↑ Y/Y)
Treasury stock, at cost
(144,090 and 140,794...
$2,078K
(0.43%↑ Y/Y)
Additional paid-in capital
$234,608K
(-0.09%↓ Y/Y)
Other long-term
liabilities
$5,838K
(7.61%↑ Y/Y)
Total current
liabilities
$4,951K
(-30.75%↓ Y/Y)
Operating lease
liabilities, net of current...
$516K
(-47.02%↓ Y/Y)
Common stock, .01 par
value 100,000,000...
$640K
(57.25%↑ Y/Y)
Other accrued
expenses
$1,784K
(25.46%↑ Y/Y)
Accounts payable
$1,555K
(24.40%↑ Y/Y)
Accrued salary and bonus
$952K
(-53.45%↓ Y/Y)
Current liabilities of
discontinued operations
$660K
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
INTERPACE BIOSCIENCES, INC. (IDXG)
INTERPACE BIOSCIENCES, INC. (IDXG)
source: myfinsight.com